INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,162 | -22.5% | 100 | 0.0% | 0.00% | – |
Q2 2023 | $4,078 | +9.4% | 100 | 0.0% | 0.00% | – |
Q1 2023 | $3,727 | +124133.3% | 100 | 0.0% | 0.00% | – |
Q4 2022 | $3 | -100.0% | 100 | 0.0% | 0.00% | – |
Q3 2022 | $6,000 | +20.0% | 100 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -28.6% | 100 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | -61.1% | 100 | -33.3% | 0.00% | – |
Q4 2021 | $18,000 | -70.0% | 150 | -66.7% | 0.00% | -100.0% |
Q3 2021 | $60,000 | +57.9% | 450 | +125.0% | 0.00% | +100.0% |
Q2 2021 | $38,000 | +137.5% | 200 | 0.0% | 0.00% | – |
Q1 2021 | $16,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |